{"entity":{"type":"insider","cik":"0001762611","url":"/insider/0001762611","json_url":"/insider/0001762611.json","name":"Aker Christopher Ray","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":15,"first":"2019-04-03","last":"2025-01-15","span_basis":"filed_date"},"name_variants":[{"name":"Aker Christopher Ray","source":"filing","n_filings":15,"first_seen":"2019-04-03","last_seen":"2025-01-15"}],"transactions":[{"id":4524767,"accession":"0000950170-25-005882","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-005882","line_url":"/filing/0000950170-25-005882#line-2","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001762611","owner_name":"Aker Christopher Ray","owner_display_name":"Aker Christopher Ray","owner_url":"/insider/0001762611","role":"Officer (Sr. VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5088.0,"shares_display":"5,088","price_per_share":1.2632,"price_display":"1.26","price_state":"stated","total_value":6427.1616,"total_display":"6,427.16","total_whole":"6,427","shares_owned_after":49546.0,"shares_owned_after_display":"49,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-14","filed_date":"2025-01-15","scope":"insider"},{"id":4524762,"accession":"0000950170-25-005882","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-005882","line_url":"/filing/0000950170-25-005882#line-1","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001762611","owner_name":"Aker Christopher Ray","owner_display_name":"Aker Christopher Ray","owner_url":"/insider/0001762611","role":"Officer (Sr. VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38547.0,"shares_display":"38,547","price_per_share":1.2632,"price_display":"1.26","price_state":"stated","total_value":48692.5704,"total_display":"48,692.57","total_whole":"48,693","shares_owned_after":54634.0,"shares_owned_after_display":"54,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-13","filed_date":"2025-01-15","scope":"insider"},{"id":2037794,"accession":"0001209191-24-001874","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-001874","line_url":"/filing/0001209191-24-001874#line-1","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001762611","owner_name":"Aker Christopher Ray","owner_display_name":"Aker Christopher Ray","owner_url":"/insider/0001762611","role":"Officer (Sr. VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5468.0,"shares_display":"5,468","price_per_share":1.1906,"price_display":"1.19","price_state":"stated","total_value":6510.2008,"total_display":"6,510.20","total_whole":"6,510","shares_owned_after":10056.0,"shares_owned_after_display":"10,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-18","filed_date":"2024-01-18","scope":"insider"},{"id":4273387,"accession":"0001209191-21-033296","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-033296","line_url":"/filing/0001209191-21-033296#line-1","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001762611","owner_name":"Aker Christopher Ray","owner_display_name":"Aker Christopher Ray","owner_url":"/insider/0001762611","role":"Officer (Sr. VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":860.0,"shares_display":"860","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":765.4,"total_display":"765.40","total_whole":"765","shares_owned_after":41754.0,"shares_owned_after_display":"41,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-17","scope":"insider"},{"id":5145118,"accession":"0001209191-21-011379","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-011379","line_url":"/filing/0001209191-21-011379#line-1","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001762611","owner_name":"Aker Christopher Ray","owner_display_name":"Aker Christopher Ray","owner_url":"/insider/0001762611","role":"Officer (Sr. VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":828.0,"shares_display":"828","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":1424.16,"total_display":"1,424.16","total_whole":"1,424","shares_owned_after":42614.0,"shares_owned_after_display":"42,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-17","scope":"insider"},{"id":3208761,"accession":"0001209191-20-059054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-059054","line_url":"/filing/0001209191-20-059054#line-1","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001762611","owner_name":"Aker Christopher Ray","owner_display_name":"Aker Christopher Ray","owner_url":"/insider/0001762611","role":"Officer (Sr. VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":876.0,"shares_display":"876","price_per_share":0.5211,"price_display":"0.52","price_state":"stated","total_value":456.4836,"total_display":"456.48","total_whole":"456","shares_owned_after":25762.0,"shares_owned_after_display":"25,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-18","scope":"insider"},{"id":2111677,"accession":"0001209191-20-047031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047031","line_url":"/filing/0001209191-20-047031#line-1","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001762611","owner_name":"Aker Christopher Ray","owner_display_name":"Aker Christopher Ray","owner_url":"/insider/0001762611","role":"Officer (Sr. VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":872.0,"shares_display":"872","price_per_share":0.605,"price_display":"0.60","price_state":"stated","total_value":527.56,"total_display":"527.56","total_whole":"528","shares_owned_after":26638.0,"shares_owned_after_display":"26,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-14","filed_date":"2020-08-17","scope":"insider"},{"id":2965715,"accession":"0001209191-20-030087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-030087","line_url":"/filing/0001209191-20-030087#line-1","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001762611","owner_name":"Aker Christopher Ray","owner_display_name":"Aker Christopher Ray","owner_url":"/insider/0001762611","role":"Officer (Sr. VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":909.0,"shares_display":"909","price_per_share":0.6268,"price_display":"0.63","price_state":"stated","total_value":569.7612,"total_display":"569.76","total_whole":"570","shares_owned_after":27510.0,"shares_owned_after_display":"27,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-15","filed_date":"2020-05-18","scope":"insider"},{"id":2433779,"accession":"0001209191-20-010752","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-010752","line_url":"/filing/0001209191-20-010752#line-1","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001762611","owner_name":"Aker Christopher Ray","owner_display_name":"Aker Christopher Ray","owner_url":"/insider/0001762611","role":"Officer (Sr. VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":888.0,"shares_display":"888","price_per_share":0.8305,"price_display":"0.83","price_state":"stated","total_value":737.484,"total_display":"737.48","total_whole":"737","shares_owned_after":28419.0,"shares_owned_after_display":"28,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-18","filed_date":"2020-02-19","scope":"insider"},{"id":3294458,"accession":"0001209191-20-000777","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-000777","line_url":"/filing/0001209191-20-000777#line-1","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001762611","owner_name":"Aker Christopher Ray","owner_display_name":"Aker Christopher Ray","owner_url":"/insider/0001762611","role":"Officer (Sr. VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2239.0,"shares_display":"2,239","price_per_share":0.9667,"price_display":"0.97","price_state":"stated","total_value":2164.4413,"total_display":"2,164.44","total_whole":"2,164","shares_owned_after":29307.0,"shares_owned_after_display":"29,307","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-03","scope":"insider"},{"id":7928876,"accession":"0001209191-19-056800","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-056800","line_url":"/filing/0001209191-19-056800#line-1","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001762611","owner_name":"Aker Christopher Ray","owner_display_name":"Aker Christopher Ray","owner_url":"/insider/0001762611","role":"Officer (Sr. VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":833.0,"shares_display":"833","price_per_share":0.64,"price_display":"0.64","price_state":"stated","total_value":533.12,"total_display":"533.12","total_whole":"533","shares_owned_after":31546.0,"shares_owned_after_display":"31,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-14","filed_date":"2019-11-15","scope":"insider"},{"id":8677470,"accession":"0001209191-19-051945","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-051945","line_url":"/filing/0001209191-19-051945#line-1","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001762611","owner_name":"Aker Christopher Ray","owner_display_name":"Aker Christopher Ray","owner_url":"/insider/0001762611","role":"Officer (Sr. VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2346.0,"shares_display":"2,346","price_per_share":0.6827,"price_display":"0.68","price_state":"stated","total_value":1601.6142,"total_display":"1,601.61","total_whole":"1,602","shares_owned_after":32379.0,"shares_owned_after_display":"32,379","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-01","filed_date":"2019-10-02","scope":"insider"},{"id":8728204,"accession":"0001209191-19-046312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-046312","line_url":"/filing/0001209191-19-046312#line-1","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001762611","owner_name":"Aker Christopher Ray","owner_display_name":"Aker Christopher Ray","owner_url":"/insider/0001762611","role":"Officer (Sr. VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":899.0,"shares_display":"899","price_per_share":0.5506,"price_display":"0.55","price_state":"stated","total_value":494.9894,"total_display":"494.99","total_whole":"495","shares_owned_after":34725.0,"shares_owned_after_display":"34,725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-15","filed_date":"2019-08-16","scope":"insider"},{"id":8298319,"accession":"0001209191-19-040502","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-040502","line_url":"/filing/0001209191-19-040502#line-1","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001762611","owner_name":"Aker Christopher Ray","owner_display_name":"Aker Christopher Ray","owner_url":"/insider/0001762611","role":"Officer (Sr. VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2225.0,"shares_display":"2,225","price_per_share":1.3115,"price_display":"1.31","price_state":"stated","total_value":2918.0875,"total_display":"2,918.09","total_whole":"2,918","shares_owned_after":35624.0,"shares_owned_after_display":"35,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-01","filed_date":"2019-07-02","scope":"insider"},{"id":8598600,"accession":"0001209191-19-030503","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-030503","line_url":"/filing/0001209191-19-030503#line-2","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001762611","owner_name":"Aker Christopher Ray","owner_display_name":"Aker Christopher Ray","owner_url":"/insider/0001762611","role":"Officer (Sr. VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6950.0,"shares_display":"6,950","price_per_share":1.4095,"price_display":"1.41","price_state":"stated","total_value":9796.025,"total_display":"9,796.02","total_whole":"9,796","shares_owned_after":59309.0,"shares_owned_after_display":"59,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-15","filed_date":"2019-05-16","scope":"insider"},{"id":7870890,"accession":"0001209191-19-023084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-023084","line_url":"/filing/0001209191-19-023084#line-1","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001762611","owner_name":"Aker Christopher Ray","owner_display_name":"Aker Christopher Ray","owner_url":"/insider/0001762611","role":"Officer (Sr. VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2710.0,"shares_display":"2,710","price_per_share":0.9812,"price_display":"0.98","price_state":"stated","total_value":2659.052,"total_display":"2,659.05","total_whole":"2,659","shares_owned_after":6287.0,"shares_owned_after_display":"6,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-01","filed_date":"2019-04-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001505512","name":"Regulus Therapeutics Inc.","url":"/issuer/0001505512","role":"Officer (Sr. VP & General Counsel)","n_filings":15,"first_seen":"2019-04-03","last_seen":"2025-01-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001762611","retrieved_at":"2026-08-25T19:34:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}